Advertisement
News
Subscribe to MDT Magazine News

Computational biotech CMD Bioscience finds financing

February 9, 2011 5:33 am | by Mass High Tech: The Journal of New England Technology | Comments

CMD Bioscience LLC, a computational biotechnology firm in Orange, Conn., has taken in $150,000 of a planned $225,000 mixed offering of equity, debt, warrants and options, according to a regulatory filing.

TOPICS:

Q & A: UMass Memorial Deploys Image/EHR Interoperability

February 9, 2011 5:32 am | by Diagnostic Imaging | Comments

Can you view medical images directly from your electronic health record? William Corbett, MD, vice president of community practices for UMass Memorial Health Care, discusses the center's decision to implement a system to allow just that, and the benefits they've expereinced so far.

TOPICS:

Americord Becomes Only Family Cord Blood Bank Headquartered in New York City to Hold State Cord Blood License

February 9, 2011 4:33 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 9, 2011 /- Americord Registry , a pioneer in cord blood and placenta stem cell preservation, is proud to announce that it has obtained a provisional human tissue cord blood banking license from the New York State Department of Health, becoming the first private umbilical...

TOPICS:
Advertisement

Rcadia COR Analyzer System Receives Expanded FDA Clearance to Rule Out Coronary Artery Disease in Coronary Branch Vessels

February 9, 2011 4:33 am | by Bio-Medicine.Org | Comments

NEWTON, Mass., Feb. 9, 2011 /- Rcadia Medical Imaging announced today that it has received FDA 510(k) marketing clearance for an enhanced version of its COR Analyzer® System to assess coronary branch vessels in addition to main coronary arteries in patients with suspected coronary...

TOPICS:

Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET

February 9, 2011 4:33 am | by Bio-Medicine.Org | Comments

TARRYTOWN, N.Y., Feb. 9, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that it will webcast an investor briefing on Sunday, February 13 from 9 a.m. to 10:30 a.m. Eastern Time.  At the investor briefing, principal investigators from the VEGF Trap-Eye clinical...

TOPICS:

PARI Respiratory Launches New Website

February 9, 2011 4:33 am | by Bio-Medicine.Org | Comments

MIDLOTHIAN, Va., Feb. 9, 2011 /- Today, PARI Respiratory Equipment launched an updated company website at www.pari.com .  In addition to providing visitors with a beautiful new interface, the website includes easy access to: Continuing Education classes Product instructional videos...

TOPICS:

NOVAVAX to Present H1N1 VLP Influenza Vaccine Clinical Data at 7th World Health Organization (WHO) Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials

February 9, 2011 4:33 am | by Bio-Medicine.Org | Comments

ROCKVILLE, Md., Feb. 9, 2011 /- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr. Gregory Glenn, Chief Medical Officer of Novavax, will be presenting safety and immunogenicity data from its pivotal 2009 A/H1N1 virus-like particle (VLP) pandemic...

TOPICS:

Federal Register: Medical Device Innovation Initiative; Request for Comments

February 9, 2011 4:31 am | by U.S. Food & Drug Administration | Comments

The report proposes potential actions for FDA's CDRH to facilitate the development, assessment, and regulatory review of innovative medical devices.

TOPICS:
Advertisement

Federal Register: Medical Device Innovation Initiative; Public Meeting; Request for Comments

February 9, 2011 4:30 am | by U.S. Food & Drug Administration | Comments

FDA is seeking input on a number of identified challenges associated with incentivizing innovation, and the proposed solutions. In addition, the Agency requests comments on the Innovation Pathway proposed under the report.

TOPICS:

Intuitive Surgical board OKs $400M share buyback

February 9, 2011 3:45 am | by The Associated Press | Comments

Intuitive Surgical Inc. said its board has authorized the buyback of up to an additional $298.8 million of the company's outstanding shares, boosting the total available for repurchasing stock to $400 million.The Sunnyvale, Calif., company, which makes the minimally invasive, robotic da Vinci...

NeurogesX to Present at Two February Investor Conferences

February 8, 2011 9:34 pm | by Bio-Medicine.Org | Comments

SAN MATEO, Calif., Feb. 8, 2011 /- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at two upcoming...

TOPICS:

Allied Healthcare Products Reports Modest Profit for Quarter

February 8, 2011 9:33 pm | by Bio-Medicine.Org | Comments

ST. LOUIS, Feb. 8, 2011 /- With its governmental markets still depressed, Allied Healthcare Products (Nasdaq: AHPI ) earned a modest profit in the second quarter of fiscal year 2011 and improvement in its year-over-year performance. Net income for the quarter ending December 31 was...

TOPICS:

Collaboration agreement announced between ITRI, Taiwan and Oxford Instruments

February 8, 2011 7:37 pm | by I-Micronews | Comments

Oxford Instruments and the Industrial Technology Research Institute in Taiwan (ITRI) are delighted to announce that they have just signed a research-based collaboration agreement.

Edwards Lifesciences Comments on U.S. Court Ruling

February 8, 2011 3:45 pm | by The Associated Press | Comments

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that the U.S. District Court for the District of Delaware reaffirmed an April 2010 federal jury decision that determined Medtronic CoreValve LLC...

Neuro Resource Group, Inc. Informs Customers of Important Information About Triad Group's Alcohol Prep Pads

February 8, 2011 2:46 pm | by The Associated Press | Comments

http://www.nrg-unlimited.com () —Neuro Resource Group, Inc. (NRG) has become aware of the market recall of Triad Group's alcohol prep pads, alcohol swabs, and alcohol swabsticks manufactured by Triad in the United States and marketed under various brand names, ...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading